IP Library Assignment 039264/0377
Patent Assignment
Reel/Frame 039264/0377

Change of Name

Recorded: 2016-07-26 Pages: 8
Assignor
OXIGENE, INC.
Executed: 2016-06-16
Assignee
MATEON THERAPEUTICS, INC.
701 GATEWAY BOULEVARD, SUITE 210, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (18)
Compositions and Methods for Use in Targeting Vascular Destruction
Patent: 6,538,038 →
Application: 09/505,402 →
Tubulin Binding Ligands and Corresponding Prodrug Constructs
Patent: 6,593,374 →
Application: 09/804,280 →
Publication: US 2002/0055643
Efficient Method of Synthesizing Combretastatin a-4 Prodrugs
Patent: 6,743,937 →
Application: 09/908,321 →
Publication: US 2002/0119951
Methods for Modulating Tumor Growth and Metastasis
Patent: 7,037,906 →
Application: 10/027,186 →
Use of Combretastatin A4 and Its Prodrugs as an Immune Enhancing Therapy
Patent: 6,773,702 →
Application: 10/034,746 →
Publication: US 2002/0160973
Compositions and Methods for Use in Targeting Vascular Destruction
Patent: 6,956,054 →
Application: 10/218,833 →
Publication: US 2003/0109500
Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents
Patent: 6,919,324 →
Application: 10/281,528 →
Publication: US 2003/0149003
Tubulin Binding Agents and Corresponding Prodrug Constructs
Patent: 7,001,926 →
Application: 10/404,525 →
Publication: US 2004/0043969
Tubulin Binding Ligands and Corresponding Prodrug Constructs
Patent: 7,091,240 →
Application: 10/425,462 →
Publication: US 2004/0044059
Control of Acute Hypertension and Cardiotoxicity in Patients Treated with Vascular Targeting Agents
Patent: 7,358,236 →
Application: 10/602,325 →
Compositions and Methods with Enhanced Therapeutic Activity
Patent: 8,198,302 →
Application: 10/790,662 →
Publication: US 2004/0242696
Chromene-Containing Compounds with Anti-Tubulin and Vascular Targeting Activity
Patent: 7,456,214 →
Application: 10/851,445 →
Publication: US 2005/0245490
Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents
Patent: 7,384,925 →
Application: 11/183,556 →
Publication: US 2006/0035868
Method for Treating Hematopoietic Neoplasms
Patent: 9,040,500 →
Application: 13/305,612 →
Publication: US 2012/0270831
Compositions and Methods for Inhibition of Cathepsins
Patent: 8,877,967 →
Application: 13/786,142 →
Publication: US 2013/0296605
Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents
Patent: 45,720 →
Application: 14/180,209 →
Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents
Patent: 45,907 →
Application: 14/180,238 →
Compositions and Methods for Inhibition of Cathepsins
Patent: 9,458,103 →
Application: 14/505,165 →
Publication: US 2015/0031915
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 12, 2000
From: SHERRIS, DAVID
To: OXIGENE, INC.
Reel/Frame 010831/0089 →
Assignment of Assignor's Interest Aug 21, 2000
From: PERO, RONALD W.
To: OXIGENE, INC.
Reel/Frame 011150/0394 →
Assignment of Assignor's Interest Feb 28, 2002
From: SEYEDI, FAYE; HOARE, JOHN
To: JOHNSON MATTHEY PHARMACEUTICAL MATERIALS, INC.
Reel/Frame 012658/0868 →
Assignment of Assignor's Interest Mar 14, 2002
From: LEE, FRANCIS Y.; PECK, RONALD
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 012481/0956 →
Assignment of Assignor's Interest Mar 20, 2002
From: EDVARDSEN, KLAUS
To: OXYGENE, INC.; BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 012705/0365 →
Assignment of Assignor's Interest Mar 20, 2002
From: PERO, RONALD W.
To: OXIGENE, INC.; BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 012708/0723 →
Assignment of Assignor's Interest Mar 20, 2002
From: SJOGREN, HANS OLOV
To: OXIGENT, INC,; BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 012705/0373 →
Assignment of Assignor's Interest Mar 20, 2002
From: LEE, FRANCIS Y.F.
To: OXIGENE, INC.; BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 012705/0369 →
Assignment of Assignor's Interest Jun 6, 2002
From: EDVARDSEN, KLAUS
To: OXIGENE, INC.; BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 012966/0931 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded on Reel 012705 Frame 0373 Assignor Hereby Confirms the Assignment of the Entire Interest. Jun 6, 2002
From: SJOGREN, HANS OLOV
To: OXIGENE, INC.; BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 012996/0301 →
Assignment of Assignor's Interest Jun 24, 2002
From: CHAPLIN, DAVID; PERO, RONALD; EDVARDSEN, KLAUS
To: OXIGENE, INC.
Reel/Frame 013031/0196 →
Assignment of Assignor's Interest Jun 27, 2002
From: JOHNSON MATTHEY PHARMACEUTICAL MATERIALS, INC. (FORMERLY KNOWN AS PHARM-ECO LABORATORIES, INC.)
To: OXIGENE, INC.
Reel/Frame 013047/0815 →
Assignment of Assignor's Interest Oct 24, 2002
From: PINNEY, KEVIN G.; MOCHARLA, VANI P.; CHEN, ZHI
To: BAYLOR UNIVERSITY
Reel/Frame 013423/0440 →
Assignment of Assignor's Interest Jan 23, 2003
From: CHAPLIN, DAVID J.; PREZIOSO, JOSEPH ANTHONY; EDVARDSEN, KLAUS
To: OXIGENE, INC.
Reel/Frame 013692/0021 →
Assignment of Assignor's Interest Oct 23, 2003
From: EDVARDSEN, KLAUS; CHAPLIN, DAVID J.; PREZIOSO, JOSEPH
To: OXIGENE, INC.
Reel/Frame 014621/0168 →
Assignment of Assignor's Interest Oct 23, 2003
From: PINNEY, KEVIN G.; MOCHARLA, VANI P.; CHEN, ZHI; GARNER, CHARLES M.
To: BAYLOR UNIVERSITY
Reel/Frame 014620/0042 →
Assignment of Assignor's Interest Oct 24, 2003
From: GHATAK, ANJAN
To: BAYLOR UNIVERSITY
Reel/Frame 014628/0631 →
Assignment of Assignor's Interest Oct 24, 2003
From: PINNEY, KEVIN G.; MOCHARLA, VANI P.; CHEN, ZHI; GARNER, CHARLES M.
To: BAYLOR UNIVERSITY
Reel/Frame 014621/0840 →
Assignment of Assignor's Interest Oct 25, 2003
From: CHAPLIN, DAVID J.; PREZIOSO, JOSEPH; EDVARDSEN, KLAUS
To: OXIGENE, INC.
Reel/Frame 014622/0008 →
Assignment of Assignor's Interest Nov 25, 2003
From: CHAPLIN, DAVID; YOUNG, SCOTT
To: OXIGENE, INC.
Reel/Frame 014732/0519 →
Assignment of Assignor's Interest May 11, 2004
From: GARNER, CHARLES M., III; KANE, ROBERT R.; PINNEY, KEVIN G.
To: BAYLOR UNIVERSITY
Reel/Frame 015314/0848 →
Assignment of Assignor's Interest May 25, 2004
From: GHATAK, ANJAN (DECEASED) BY USHA R. GHATAK, LEGAL REPRESENTATIVE
To: BAYLOR UNIVERSITY
Reel/Frame 015397/0874 →
Assignment of Assignor's Interest Jul 16, 2004
From: PINNEY, KEVIN
To: BAYLOR UNIVERSITY
Reel/Frame 015572/0753 →
Assignment of Assignor's Interest Jul 16, 2004
From: CHAPLIN, DAVID; EDVARDSEN, KLAUS; PREZIOSO, JOSEPH; WOOD, MARK
To: OXIGENE, INC.
Reel/Frame 015573/0353 →
Assignment of Assignor's Interest Feb 18, 2005
From: PINNEY, KEVIN G.; ARTHASARY, PHYLLIS; SHIRALI, ANUPAMA
To: BAYLOR UNIVERSITY
Reel/Frame 016311/0733 →